Obesity and pulmonary hypertension: A review of pathophysiologic mechanisms

Journal of Obesity

Volumn 2012, Issue , 2012, Pages

  Friedman, Scott E ^a,b   Andrus, Bruce W ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; DIGOXIN; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTANOID; SILDENAFIL;

CARDIOMYOPATHY; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERURICEMIA; INSULIN RESISTANCE; LUNG EMBOLISM; NONHUMAN; OBESITY; OBESITY HYPOVENTILATION SYNDROME; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SLEEP DISORDERED BREATHING; STAGING; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 84867032758     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2012/505274     Document Type: Review

References (95)

1. Mukerjee D., George D. S., Knight C., Davar J., Wells A. U., Du Bois R. M., Black C. M., Coghlan J. G., Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 2004 43 4 461 466 2-s2.0-1842866218 10.1093/rheumatology/keh067 (Pubitemid 38489363)
2. McLaughlin V. V., Archer S. L., Badesch D. B., Barst R. J., Farber H. W., Lindner J. R., Mathier M. A., McGoon M. D., Park M. H., Rosenson R. S., Rubin L. J., Tapson V. F., Varga J., ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the american college of cardiology foundation task force on expert consensus documents and the american heart association developed in collaboration with the american college of chest physicians; american thoracic society, inc.; and the pulmonary hypertension association. Journal of the American College of Cardiology 2009 53 17 1573 1619 2-s2.0-64849109410 10.1016/j.jacc.2009.01.004
3. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., Yaici A., Weitzenblum E., Cordier J. F., Chabot F., Dromer C., Pison C., Reynaud-Gaubert M., Haloun A., Laurent M., Hachulla E., Simonneau G., Pulmonary arterial hypertension in France: results from a national registry. American Journal of Respiratory and Critical Care Medicine 2006 173 9 1023 1030 2-s2.0-33646269035 10.1164/rccm.200510-1668OC
4. Lam C. S., Borlaug B. A., Kane G. C., Enders F. T., Rodeheffer R. J., Redfield M. M., Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 2009 119 20 2663 2670 2-s2.0-67249136150 10.1161/CIRCULATIONAHA.108.838698
5. Hatano S., Strasser R., Primary pulmonary hypertension. World Heath Organization, Geneva, Switzerland, 1975
6. Simonneau G., Robbins I. M., Beghetti M., Channick R. N., Delcroix M., Denton C. P., Elliott C. G., Gaine S. P., Gladwin M. T., Jing Z. C., Krowka M. J., Langleben D., Nakanishi N., Souza R., Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology 2009 54 1, supplement S43 S54 2-s2.0-67649579669 10.1016/j.jacc.2009.04.012
7. Thenappan T., Shah S. J., Rich S., Gomberg-Maitland M., A USA-based registry for pulmonary arterial hypertension: 19822006. European Respiratory Journal 2007 30 6 1103 1110 2-s2.0-37549033243 10.1183/09031936.00042107 (Pubitemid 351194756)
8. Hoeper M. M., Barberà J. A., Channick R. N., Hassoun P. M., Lang I. M., Manes A., Martinez F. J., Naeije R., Olschewski H., Pepke-Zaba J., Redfield M. M., Robbins I. M., Souza R., Torbicki A., McGoon M., Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. Journal of the American College of Cardiology 2009 54 1, supplement S85 S96 2-s2.0-67649613565 10.1016/j.jacc.2009.04.008
9. Ogden C. L., Carroll M. D., Kit B. K., Flegal K. M., Prevalence of obesity and trends in body mass index among US children and adolescents, 19992010. The Journal of the American Medical Association 2012 307 5 483 490
10. Field A. E., Coakley E. H., Must A., Spadano J. L., Laird N., Dietz W. H., Rimm E., Colditz G. A., Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Archives of Internal Medicine 2001 161 13 1581 1586 2-s2.0-0034917709 (Pubitemid 32681139)
11. McQuillan B. M., Picard M. H., Leavitt M., Weyman A. E., Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001 104 23 2797 2802 2-s2.0-0035808004 (Pubitemid 33126653)
12. Taraseviciute A., Voelkel N. F., Severe pulmonary hypertension in postmenopausal obese women. European Journal of Medical Research 2006 11 5 198 202 2-s2.0-33646731984
13. Wong C. Y., O'Moore-Sullivan T., Leano R., Hukins C., Jenkins C., Marwick T. H., Association of subclinical right ventricular dysfunction with obesity. Journal of the American College of Cardiology 2006 47 3 611 616 2-s2.0-31644449401 10.1016/j.jacc.2005.11.015 (Pubitemid 43170853)
14. Dela Cruz C. S., Matthay R. A., Role of obesity in cardiomyopathy and pulmonary hypertension. Clinics in Chest Medicine 2009 30 3 509 523 2-s2.0-68949149092 10.1016/j.ccm.2009.06.001
15. Leung C. C., Moondra V., Catherwood E., Andrus B. W., Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. American Journal of Cardiology 2010 106 2 284 286 2-s2.0-77955676030 10.1016/j.amjcard.2010.02.039
16. Somers V. K., White D. P., Amin R., Sleep apnea and cardiovascular disease: An American Heart Association/american college of cardiology foundation scientific statement from the american heart association council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. in collaboration with the national heart, lung, and blood institute national center on sleep disorders research (National Institutes of Health). Circulation 2008 118 10 1080 1111
17. Atwood C. W. Jr., McCrory D., Garcia J. G., Abman S. H., Ahearn G. S., Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest 2004 126 1, supplement 72S 77S 2-s2.0-3142666018 10.1378/chest.126.1suppl.72S (Pubitemid 38932343)
18. Vgontzas A. N., Tan T. L., Bixler E. O., Martin L. F., Shubert D., Kales A., Sleep apnea and sleep disruption in obese patients. Archives of Internal Medicine 1994 154 15 1705 1711 2-s2.0-0028102601 10.1001/archinte.154.15.1705 (Pubitemid 24250629)
19. Bady E., Achkar A., Pascal S., Orvoen-Frija E., Laaban J. P., Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax 2000 55 11 934 939 2-s2.0-0033767552 10.1136/thorax.55.11.934
20. Sajkov D., Wang T., Saunders N. A., Bune A. J., Neill A. M., McEvoy R. D., Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. American Journal of Respiratory and Critical Care Medicine 1999 159 5, part 1 1518 1526 2-s2.0-0032935228 (Pubitemid 29227863)
21. Sajkov D., McEvoy R. D., Obstructive sleep apnea and pulmonary hypertension. Progress in Cardiovascular Diseases 2009 51 5 363 370 2-s2.0-60649085826 10.1016/j.pcad.2008.06.001
22. Chaouat A., Weitzenblum E., Krieger J., Oswald M., Kessler R., Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996 109 2 380 386 2-s2.0-0030024303
23. Kato M., Roberts-Thomson P., Phillips B. G., Haynes W. G., Winnicki M., Accurso V., Somers V. K., Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000 102 21 2607 2610 2-s2.0-0034700285
24. Campen M. J., Shimoda L. A., O'Donnell C. P., Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. Journal of Applied Physiology 2005 99 5 2028 2035 2-s2.0-27544471763 10.1152/japplphysiol. 00411.2005 (Pubitemid 41547206)
25. McGuire M., Bradford A., Chronic intermittent hypercapnic hypoxia increases pulmonary arterial pressure and haematocrit in rats. European Respiratory Journal 2001 18 2 279 285 2-s2.0-0034886023 10.1183/09031936.01. 00078801 (Pubitemid 32776402)
26. Valencia-Flores M., Rebollar V., Santiago V., Orea A., Rodríguez C., Resendiz M., Castaño A., Roblero J., Campos R. M., Oseguera J., Garcĩa-Ramos G., Bliwise D. L., Prevalence of pulmonary hypertension and its association with respiratory disturbances in obese patients living at moderately high altitude. International Journal of Obesity 2004 28 9 1174 1180 2-s2.0-4344626579 10.1038/sj.ijo.0802726 (Pubitemid 39141557)
27. Minai O. A., Ricaurte B., Kaw R., Hammel J., Mansour M., McCarthy K., Golish J. A., Stoller J. K., Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. American Journal of Cardiology 2009 104 9 1300 1306 2-s2.0-71749112811 10.1016/j.amjcard.2009.06.048
28. Mokhlesi B., Obesity hypoventilation syndrome: a state-of-the-art review. Respiratory Care 2010 55 10 1347 1362 2-s2.0-78149397001
29. Arias M. A., García-Río F., Alonso-Fernández A., Martínez I., Villamor J., Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. European Heart Journal 2006 27 9 1106 1113 2-s2.0-33646239843 10.1093/eurheartj/ehi807
30. Guidry U. C., Mendes L. A., Evans J. C., Levy D., O'Connor G. T., Larson M. G., Gottlieb D. J., Benjamin E. J., Echocardiographic features of the right heart in sleep-disordered breathing: The Framingham Heart Study. American Journal of Respiratory and Critical Care Medicine 2001 164 6 933 938 2-s2.0-0035883490 (Pubitemid 32971635)
31. Dursunolu N., Dursunolu D., Kiliç M., Impact of obstructive sleep apnea on right ventricular global function: sleep apnea and myocardial performance index. Respiration 2005 72 3 278 284 2-s2.0-22144482398 10.1159/000085369 (Pubitemid 40981087)
32. Romero-Corral A., Somers V. K., Pellikka P. A., Olson E. J., Bailey K. R., Korinek J., Orban M., Sierra-Johnson J., Kato M., Amin R. S., Lopez-Jimenez F., Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest 2007 132 6 1863 1870 2-s2.0-37549066967 10.1378/chest.07-0966
33. Budhiraja R., Parthasarathy S., Quan S. F., Endothelial dysfunction in obstructive sleep apnea. Journal of Clinical Sleep Medicine 2007 3 4 409 415 2-s2.0-34250856934 (Pubitemid 46984039)
34. El-Solh A. A., Akinnusi M. E., Moitheennazima B., Ayyar L., Relia S., Endothelial function in patients with post-CPAP residual sleepiness. Journal of Clinical Sleep Medicine 2010 6 3 251 255 2-s2.0-77954101075
35. Nowbar S., Burkart K. M., Gonzales R., Fedorowicz A., Gozansky W. S., Gaudio J. C., Taylor M. R. G., Zwillich C. W., Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. American Journal of Medicine 2004 116 1 1 7 2-s2.0-0346969989 10.1016/j.amjmed.2003.08.022 (Pubitemid 38050019)
36. Kessler R., Chaouat A., Weitzenblum E., Oswald M., Ehrhart M., Apprill M., Krieger J., Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. European Respiratory Journal 1996 9 4 787 794 2-s2.0-0029949783 10.1183/09031936.96.09040787 (Pubitemid 26167887)
37. Sugerman H. J., Baron P. L., Fairman R. P., Evans C. R., Vetrovec G. W., Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Annals of Surgery 1988 207 5 604 613 2-s2.0-0023882862
38. Berg G., Delaive K., Manfreda J., Walld R., Kryger M. H., The use of health-care resources in obesity-hypoventilation syndrome. Chest 2001 120 2 377 383 2-s2.0-0034821156 10.1378/chest.120.2.377 (Pubitemid 32881250)
39. Masa J. F., Celli B. R., Riesco J. A., Hernández M., Sánchez de Cos J., Disdier C., The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest 2001 119 4 1102 1107 2-s2.0-0034920252 10.1378/chest.119.4.1102 (Pubitemid 32679437)
40. Haines K. L., Nelson L. G., Gonzalez R., Torrella T., Martin T., Kandil A., Dragotti R., Anderson W. M., Gallagher S. F., Murr M. M., Objective evidence that bariatric surgery improves obesity-related obstructive sleep apnea. Surgery 2007 141 3 354 358 2-s2.0-33847647665 10.1016/j.surg.2006.08.012 (Pubitemid 46356437)
41. Sugerman H. J., Fairman R. P., Sood R. K., Engle K., Wolfe L., Kellum J. M., Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. American Journal of Clinical Nutrition 1992 55 2, supplement 597S 601S 2-s2.0-0026598694
42. Michelakis E. D., Weir E. K., Anorectic drugs and pulmonary hypertension from the bedside to the bench. American Journal of the Medical Sciences 2001 321 4 292 299 2-s2.0-0035057728 (Pubitemid 32275937)
43. Abenhaim L., Moride Y., Brenot F., Rich S., Benichou J., Kurz X., Higenbottam T., Oakley C., Wouters E., Aubier M., Simonneau G., Bégaud B., Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. The New England Journal of Medicine 1996 335 9 609 616 2-s2.0-9444287592 10.1056/ NEJM199608293350901 (Pubitemid 26277950)
44. Souza R., Humbert M., Sztrymf B., Jaïs X., Yaïci A., Le Pavec J., Parent F., Hervé P., Soubrier F., Sitbon O., Simonneau G., Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. European Respiratory Journal 2008 31 2 343 348 2-s2.0-40649100110 10.1183/09031936.00104807
45. MacLean M. R., Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action? Trends in Pharmacological Sciences 1999 20 12 490 495 2-s2.0-0033404424 10.1016/S0165-6147(99)01389-9 (Pubitemid 30004021)
46. MacLean M. R., Dempsie Y., Serotonin and pulmonary hypertension-from bench to bedside? Current Opinion in Pharmacology 2009 9 3 281 286 2-s2.0-65749112929 10.1016/j.coph.2009.02.005
47. Hunt S. A., American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the american college of Cardiology/American heart association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). Journal of the American College of Cardiology 2005 46 6 e1 e82
48. Kenchaiah S., Evans J. C., Levy D., Wilson P. W. F., Benjamin E. J., Larson M. G., Kannel W. B., Vasan R. S., Obesity and the risk of heart failure. The New England Journal of Medicine 2002 347 5 305 313 2-s2.0-0036681988 10.1056/NEJMoa020245 (Pubitemid 34815352)
49. Wong C. Y., O'Moore-Sullivan T., Leano R., Byrne N., Beller E., Marwick T. H., Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004 110 19 3081 3087 2-s2.0-8544283794 10.1161/01.CIR.0000147184.13872.0F (Pubitemid 39492002)
50. Segers V. F., Brutsaert D. L., De Keulenaer G. W., Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction: pathophysiology and natural history. Current Opinion in Cardiology 2012 27 3 273 280
51. Rijzewijk L. J., van der Meer R. W., Smit J. W., Diamant M., Bax J. J., Hammer S., Romijn J. A., de Roos A., Lamb H. J., Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. Journal of the American College of Cardiology 2008 52 22 1793 1799 2-s2.0-55949119360 10.1016/j.jacc.2008.07.062
52. Wong C., Marwick T. H., Obesity cardiomyopathy: pathogenesis and pathophysiology. Nature Clinical Practice Cardiovascular Medicine 2007 4 8 436 443 (Pubitemid 47189016)
53. Zhou Y. T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., Orci L., Unger R. H., Lipotoxic heart disease in obese rats: implications for human obesity. Proceedings of the National Academy of Sciences of the United States of America 2000 97 4 1784 1789 2-s2.0-0034652225 10.1073/pnas.97.4.1784 (Pubitemid 30118520)
54. Rijzewijk L. J., van der Meer R. W., Lamb H. J., de Jong H. W., Lubberink M., Romijn J. A., Bax J. J., de Roos A., Twisk J. W., Heine R. J., Lammertsma A. A., Smit J. W., Diamant M., Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. Journal of the American College of Cardiology 2009 54 16 1524 1532 2-s2.0-70350459556
55. Rijzewijk L. J., Jonker J. T., van der Meer R. W., Lubberink M., De Jong H. W., Romijn J. A., Bax J. J., De Roos A., Heine R. J., Twisk J. W., Windhorst A. D., Lammertsma A. A., Smit J. W. A., Diamant M., Lamb H. J., Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. Journal of the American College of Cardiology 2010 56 3 225 233 2-s2.0-77955060310 10.1016/j.jacc.2010.02.049
56. Wong C., Marwick T. H., Obesity cardiomyopathy: diagnosis and therapeutic implications. Nature Clinical Practice Cardiovascular Medicine 2007 4 9 480 490 (Pubitemid 47321548)
57. Alpert M. A., Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. American Journal of the Medical Sciences 2001 321 4 225 236 2-s2.0-0035064965 (Pubitemid 32275931)
58. Powell B. D., Redfield M. M., Bybee K. A., Freeman W. K., Rihal C. S., Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. American Journal of Cardiology 2006 98 1 116 120 2-s2.0-33745148603 10.1016/j.amjcard.2006.01.063 (Pubitemid 43902691)
59. Peterson L. R., Waggoner A. D., Schechtman K. B., Meyer T., Gropler R. J., Barzilai B., Dávila-Román V. G., Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. Journal of the American College of Cardiology 2004 43 8 1399 1404 2-s2.0-1942420839 10.1016/j.jacc.2003.10.062 (Pubitemid 38496345)
60. Wirth A., Kroger H., Improvement of left ventricular morphology and function in obese subjects following a diet and exercise program. International Journal of Obesity 1995 19 1 61 66 2-s2.0-0028873028
61. Wong C. Y., Byrne N. M., O'Moore-Sullivan T., Hills A. P., Prins J. B., Marwick T. H., Effect of weight loss due to lifestyle intervention on subclinical cardiovascular dysfunction in obesity (body mass index >30 kg/m2). American Journal of Cardiology 2006 98 12 1593 1598 2-s2.0-34548231759 10.1016/j.amjcard.2006.07.037 (Pubitemid 44827966)
62. Pengo V., Lensing A. W., Prins M. H., Marchiori A., Davidson B. L., Tiozzo F., Albanese P., Biasiolo A., Pegoraro C., Iliceto S., Prandoni P., Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. The New England Journal of Medicine 2004 350 22 2257 2264 2-s2.0-2442643903 10.1056/NEJMoa032274 (Pubitemid 38669208)
63. Tapson V. F., Decousus H., Pini M., Chong B. H., Froehlich J. B., Monreal M., Spyropoulos A. C., Merli G. J., Zotz R. B., Bergmann J. F., Pavanello R., Turpie A. G., Nakamura M., Piovella F., Kakkar A. K., Spencer F. A., Fitzgerald G., Anderson F. A., Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007 132 3 936 945 2-s2.0-35448940890 10.1378/chest.06-2993
64. Goldhaber S. Z., Epidemiology of pulmonary embolism. Seminars in Vascular Medicine 2001 1 2 139 146 2-s2.0-3142733791
65. Goldhaber S. Z., Savage D. D., Garrison R. J., Risk factors for pulmonary embolism. The Framingham Study. American Journal of Medicine 1983 74 6 1023 1028 2-s2.0-0020528194 (Pubitemid 13101585)
66. Movahed M. R., Hashemzadeh M., Jamal M. M., The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. Chest 2005 128 5 3568 3571 2-s2.0-28144434185 10.1378/chest.128.5.3568 (Pubitemid 41698694)
67. Bokinsky G., Miller M., Ault K., Husband P., Mitchell J., Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 1995 108 3 625 630 2-s2.0-0029155669
68. Rangemark C., Hedner J. A., Carlson J. T., Gleerup G., Winther K., Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep 1995 18 3 188 194 2-s2.0-0028901241
69. Rosenberg R. D., Aird W. C., Vascular-bed-specific hemo stasis and hypercoagulable states. The New England Journal of Medicine 1999 340 20 1555 1564 2-s2.0-0033586986 10.1056/NEJM199905203402007 (Pubitemid 29228186)
70. Zamanian R. T., Hansmann G., Snook S., Lilienfeld D., Rappaport K. M., Reaven G. M., Rabinovitch M., Doyle R. L., Insulin resistance in pulmonary arterial hypertension. European Respiratory Journal 2009 33 2 318 324 2-s2.0-59649112895 10.1183/09031936.00000508
71. Fouty B., Diabetes and the pulmonary circulation. American Journal of Physiology 2008 295 5 L725 L726 2-s2.0-57049101666 10.1152/ajplung.90482.2008
72. Carlson J. T., Rångemark C., Hedner J. A., Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. Journal of Hypertension 1996 14 5 577 584 2-s2.0-0029977318 10.1097/00004872-199605000- 00006 (Pubitemid 26161112)
73. Murugan A. T., Sharma G., Obesity and respiratory diseases. Chronic Respiratory Disease 2008 5 4 233 242 2-s2.0-57449115906 10.1177/1479972308096978
74. Ramar K., Caples S. M., Vascular changes, cardiovascular disease and obstructive sleep apnea. Future Cardiology 2011 7 2 241 249 2-s2.0-79953742175 10.2217/fca.10.123
75. Lopez-Lopez J. G., Moral-Sanz J., Frazziano G., Gomez-Villalobos M. J., Moreno L., Menendez C., Flores-Hernandez J., Lorente J. A., Cogolludo A., Perez-Vizcaino F., Type 1 diabetes-induced hyper-responsiveness to 5-hydroxytryptamine in rat pulmonary arteries via oxidative stress and induction of cyclooxygenase-2. Journal of Pharmacology and Experimental Therapeutics 2011 338 1 400 407 2-s2.0-79959525067 10.1124/jpet.111.179515
76. Moral-Sanz J., Menendez C., Moreno L., Moreno E., Cogolludo A., Perez-Vizcaino F., Pulmonary arterial dysfunction in insulin resistant obese Zucker rats. Respiratory Research 2011 12, article 51 2-s2.0-79955021792 10.1186/1465-9921-12-51
77. Lopez-Lopez J. G., Moral-Sanz J., Frazziano G., Gomez-Villalobos M. J., Flores-Hernandez J., Monjaraz E., Cogolludo A., Perez-Vizcaino F., Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. American Journal of Physiology 2008 295 5 L727 L732 2-s2.0-57049086851 10.1152/ajplung.90354.2008
78. Moral-Sanz J., Lopez-Lopez J. G., Menendez C., Different patterns of pulmonary vascular disease induced by type 1 diabetes and moderate hypoxia in rats. Experimental Physiology 2012 97 5 676 686
79. Crossno J. T. Jr., Garat C. V., Reusch J. E., Morris K. G., Dempsey E. C., McMurtry I. F., Stenmark K. R., Klemm D. J., Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. American Journal of Physiology 2007 292 4 L885 L897 2-s2.0-34247282656 10.1152/ajplung.00258.2006 (Pubitemid 46608235)
80. Hansmann G., Wagner R. A., Schellong S., Perez V. A. D. J., Urashima T., Wang L., Sheikh A. Y., Suen R. S., Stewart D. J., Rabinovitch M., Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor- γ activation. Circulation 2007 115 10 1275 1284 2-s2.0-33947731898 10.1161/CIRCULATIONAHA.106.663120 (Pubitemid 46594772)
81. Alchanatis M., Tourkohoriti G., Kakouros S., Kosmas E., Podaras S., Jordanoglou J. B., Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 2001 68 6 566 572 2-s2.0-0035685436 10.1159/000050574 (Pubitemid 34062928)
82. Wolk R., Kara T., Somers V. K., Sleep-disordered breathing and cardiovascular disease. Circulation 2003 108 1 9 12 2-s2.0-0037489291 10.1161/01.CIR.0000072346.56728.E4 (Pubitemid 36859012)
83. Joya-Galeana J., Fernandez M., Cervera A., Reyna S., Ghosh S., Triplitt C., Musi N., Defronzo R. A., Cersosimo E., Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects. Diabetes/Metabolism Research and Reviews 2011 27 4 373 382 2-s2.0-79955725780 10.1002/dmrr.1185
84. Kitahara H., Kobayashi Y., Iwata Y., Fujimoto Y., Komuro I., Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation. American Journal of Cardiology 2011 108 2 214 219 2-s2.0-79959735464 10.1016/j.amjcard.2011.03.029
85. Naka K. K., Papathanassiou K., Bechlioulis A., Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin. Diabetes and Vascular Disease Research 2011 8 3 195 201
86. Azhar S., Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease. Future Cardiology 2010 6 5 657 691 2-s2.0-77958060003 10.2217/fca.10.86
87. Voelkel M. A., Wynne K. M., Badesch D. B., Groves B. M., Voelkel N. F., Hyperuricemia in severe pulmonary hypertension. Chest 2000 117 1 19 24 2-s2.0-0033977972 (Pubitemid 30053614)
88. Zharikov S. I., Swenson E. R., Lanaspa M., Block E. R., Patel J. M., Johnson R. J., Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? Medical Hypotheses 2010 74 6 1069 1074 2-s2.0-77951620306 10.1016/j.mehy.2009.12.023
89. Mercuro G., Vitale C., Cerquetani E., Zoncu S., Deidda M., Fini M., Rosano G. M. C., Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. American Journal of Cardiology 2004 94 7 932 935 2-s2.0-5344274543 10.1016/j.amjcard.2004.06.032 (Pubitemid 39349561)
90. Zharikov S., Krotova K., Hu H., Baylis C., Johnson R. J., Block E. R., Patel J., Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. American Journal of Physiology 2008 295 5 C1183 C1190 2-s2.0-57349084723 10.1152/ajpcell.00075.2008 (Pubitemid 352790338)
91. Barst R. J., Gibbs J. S., Ghofrani H. A., Hoeper M. M., McLaughlin V. V., Rubin L. J., Sitbon O., Tapson V. F., Galiè N., Updated evidence-based treatment algorithm in pulmonary arterial hypertension. Journal of the American College of Cardiology 2009 54 1, supplement S78 S84 2-s2.0-67649588196 10.1016/j.jacc.2009.04.017
92. Barst R. J., Rubin L. J., Long W. A., Mcgoon M. D., Rich S., Badesch D. B., Groves B. M., Tapson V. F., Bourge R. C., Brundage B. H., Koerner S. K., Langleben D., Keller C. A., Murali S., Uretsky B. F., Clayton L. M., Jöbsis M. M., Blackburn S. D., Shortino D., Crow J. W., A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The New England Journal of Medicine 1996 334 5 296 302 2-s2.0-0030031888
93. Hoeper M. M., Barberà J. A., Channick R. N., Hassoun P. M., Lang I. M., Manes A., Martinez F. J., Naeije R., Olschewski H., Pepke-Zaba J., Redfield M. M., Robbins I. M., Souza R., Torbicki A., McGoon M., Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. Journal of the American College of Cardiology 2009 54 1, supplement S85 S96 2-s2.0-67649613565 10.1016/j.jacc.2009.04.008
94. Guazzi M., Vicenzi M., Arena R., Guazzi M. D., Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 2011 124 2 164 174 2-s2.0-79960396933 10.1161/CIRCULATIONAHA.110.983866
95. Archibald C. J., Auger W. R., Fedullo P. F., Channick R. N., Kerr K. M., Jamieson S. W., Kapelanski D. P., Watt C. N., Moser K. M., Long-term outcome after pulmonary thromboendarterectomy. American Journal of Respiratory and Critical Care Medicine 1999 160 2 523 528 2-s2.0-0032771122 (Pubitemid 29380667)